Janux Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $818k | 59k | 13.91 |
| 2025-12-31 | $10M | 745k | 13.80 |
| 2025-09-30 | $31M | 1.3M | 24.44 |
| 2025-06-30 | $41M | 1.8M | 23.10 |
| 2025-03-31 | $38M | 1.4M | 27.00 |
| 2024-12-31 | $59M | 1.1M | 53.54 |
| 2024-09-30 | $7.2M | 159k | 45.43 |
| 2024-06-30 | $11M | 252k | 41.89 |
| 2024-03-31 | $738k | 20k | 37.68 |